THORASYS develops and brings to market innovative solutions for pulmonary assessment to offer accessible, accurate, and simplified testing for every patient along with deeper insights that are easy to interpret. Our vision is to improve the quality of life of patients with respiratory diseases by making lung function assessment as easy as taking your blood pressure.
Praxis Medical LLC
Praxis Medical is committed to developing innovative technologies that address unmet clinical needs to improve the lives of doctors, providers, and most importantly, patients. We are developing EndoCore- the world’s first motorized EBUS fine needle biopsy device. The EndoCore is designed to rotate the EBUS needle at the time of biopsy to harvest more cellular material in fewer passes. *This device is investigational.
PAREXEL
Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ | Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients. We work With HeartTM every day to treat patients with dignity and learn from their experiences, so every trial makes a difference.
MiraVista Diagnostics
MiraVista Diagnostics is a specialty diagnostic laboratory and device manufacturer committed to improved patient outcomes by developing highly accurate test solutions for the diagnosis and treatment of serious fungal infections. MiraVista specializes in testing for histoplasmosis, coccidioidomycosis, blastomycosis, aspergillosis, pneumocystis and (1–3)-β-D glucan by offering antigen, antibody, and PCR testing options. | MiraVista Diagnostics is a specialty diagnostic laboratory and device manufacturer committed to improved patient outcomes by developing highly accurate test solutions for the diagnosis and treatment of serious fungal infections. MiraVista specializes in testing for histoplasmosis, coccidioidomycosis, blastomycosis, aspergillosis, pneumocystis and (1–3)-β-D glucan by offering antigen, antibody, and PCR testing.
Electromed, Inc.
The SmartVest Airway Clearance System by Electromed, Inc. uses high frequency chest wall oscillation (HFCWO), a proven clinical therapy that helps people around the world breathe better, stay healthier, and lead active and fulfilling lives. Along with a commitment to excellence and compassionate service, Electromed is focused on the mission of making life’s important moments possible — one breath at a time.® For additional information, visit www.smartvest.com or call 800-462-1045.
Biodesix
Biodesix is a leading diagnostic solutions company, driven to improve clinical care and outcomes for patients. To deliver on our mission to transform patient care and improve outcomes through personalized diagnostics, we provide advanced diagnostic tests and custom diagnostic development services. | Biodesix is a leading diagnostic solutions and services company with a focus in lung disease. Biodesix offers five Medicare-covered tests for patients with lung diseases. The blood-based Nodify Lung® Nodule Risk Assessment testing portfolio evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. The blood based IQLung™ portfolio supports treatment decisions across all stages of lung cancer with results in an average of two to three business days, expediting the time to treatment. For more information, www.biodesix.com.
Baxter
Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. Baxter employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. Hillrom products are now part of Baxter’s global portfolio. | Baxter International Inc. through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. | Baxter products and therapies can be found throughout hospitals and clinics – from the ER to the OR, from the pharmacy to the ICU – as well as advancing patients’ care in their homes. For 90 years, we have been at the critical intersection of saving and sustaining lives. We have pioneered significant medical innovations that changed healthcare. From the first commercially produced intravenous solutions to today’s leading acute, nutritional, renal and surgical care innovations, we are committed to providing leading healthcare solutions.